000			01270 a2200313 4500
005			20250517034607.0
264		0	_c20160818
008			201608s 0 0 eng d
022			_a1873-2496
024	7		_a10.1016/j.urolonc.2015.05.006 _2doi
040			_aNLM _beng _cNLM
100	1		_aLi, Benyi
245	0	0	_aGlycogen synthase kinase-3: a potential preventive target for prostate cancer management. _h[electronic resource]
260			_bUrologic oncology _cNov 2015
300			_a456-63 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aDisease Management
650	0	4	_aGlycogen Synthase Kinase 3 _xantagonists & inhibitors
650	0	4	_aGlycogen Synthase Kinase 3 beta
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aProstatic Neoplasms _xprevention & control
650	0	4	_aSignal Transduction _xdrug effects
700	1		_aThrasher, James Brantley
700	1		_aTerranova, Paul
773	0		_tUrologic oncology _gvol. 33 _gno. 11 _gp. 456-63
856	4	0	_uhttps://doi.org/10.1016/j.urolonc.2015.05.006 _zAvailable from publisher's website
999			_c24959590 _d24959590